Chinese Compound Amino Acid Market 2021-2025 and the Impact of COVID-19 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Investigation Report on the Chinese Compound Amino Acid Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
Compound Amino Acid is clinically used for patients with insufficient protein intake, malabsorption, and other amino acids that cannot meet the requirements of body metabolism. It was developed by Japan Ajinomoto Pharmaceutical Co., Ltd.
At present, more than 20 categories of Compound Amino Acid injections have been approved in China. By 2020, in addition to Guangdong Litai Pharmaceutical Co., Ltd. in the Chinese Compound Amino Acid market, there are 34 companies, such as Guangzhou Green Cross Pharmaceutical Co., Ltd., Hubei Bantian Pharmaceutical Co., Ltd., Fujian Tianquan Pharmaceutical Co., Ltd., and Liaoning Haisco Pharmaceutical Co., Ltd.
Sales of Compound Amino Acids in the Chinese market have basically maintained a slow growth from 2016 to 2020, reaching about 1.53 billion in 2020, and the CAGR from 2016 to 2020 is about 1.8%. The main reason is that the clinical demand for Compound Amino acids is relatively stable.
The analyst predicts that with the development of Compound Amino Acid categories from 2021 to 2025, the number of indications will increase so that sales and sales volume have potential for growth. Moreover, with the addition of new manufacturers in the Chinese Compound Amino Acid market, market competition will become increasingly fierce and sales will increase as prices fall.
- The impact of COVID-19 on China's Compound Amino Acid market
- Sales value of China's Compound Amino Acid 2016-2020
- Competitive landscape of China's Compound Amino Acid market
- Prices of Compound Amino Acid in China
- Prices of Compound Amino Acid in China by regions and manufacturers
- Analysis of factors affecting the development of China's Compound Amino Acid market
- Prospect of China's Compound Amino Acid market from 2021 to 2025
- Fujian Tianquan Pharmaceutical Co.,Ltd.
- Guangdong Litai Pharmaceutical Co., Ltd.
- Guanzhou Green Cross Pharmaceutical Co.,Ltd.
- Hubei Yibantian Pharmaceutical Co.,Ltd.
- Liaoning Haisco Pharmaceutical Co.,Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/fr4amk
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900